
TY  - JOUR
TI  - Oral Presentations
JO  - Transplant International
VL  - 18
IS  - s1
SN  - 0934-0874
UR  - https://doi.org/10.1111/j.1432-2277.2005.18s1_005.x
DO  - doi:10.1111/j.1432-2277.2005.18s1_005.x
SP  - 252
EP  - 258
PY  - 2005
ER  - 

TY  - JOUR
TI  - ACRT-SCTS Scholar Abstracts
JO  - Clinical and Translational Science
VL  - 3
IS  - 2
SN  - 1752-8054
UR  - https://doi.org/10.1111/j.1752-8062.2010.00181_2.x
DO  - doi:10.1111/j.1752-8062.2010.00181_2.x
SP  - S8
EP  - S55
PY  - 2010
ER  - 

TY  - JOUR
AU  - Seewoogoolam, Gayatri
AU  - Miller, George
AU  - Tan, Beryl
TI  - Compartment syndrome of the deltoid and pectoralis major in a young man following quetiapine use
JO  - ANZ Journal of Surgery
JA  - ANZ Journal of Surgery
VL  - 89
IS  - 7-8
SN  - 1445-1433
UR  - https://doi.org/10.1111/ans.14468
DO  - doi:10.1111/ans.14468
SP  - E335
EP  - E336
PY  - 2019
ER  - 

TY  - JOUR
TI  - Oral Sessions
JO  - Transplant International
VL  - 24
IS  - s2
SN  - 0934-0874
UR  - https://doi.org/10.1111/j.1432-2277.2011.01346.x
DO  - doi:10.1111/j.1432-2277.2011.01346.x
SP  - 1
EP  - 95
PY  - 2011
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 19
IS  - S3
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.15405
DO  - doi:10.1111/ajt.15405
SP  - 310
EP  - 590
PY  - 2019
ER  - 

TY  - JOUR
TI  - The ILTS 20th Annual International Congress
JO  - Liver Transplantation
JA  - Liver Transpl
VL  - 20
IS  - S1
SN  - 1527-6465
UR  - https://doi.org/10.1002/lt.23901
DO  - doi:10.1002/lt.23901
SP  - S1
EP  - S399
PY  - 2014
ER  - 

TY  - JOUR
AU  - Fearnley, R. A.
AU  - Lines, S. W.
AU  - Lewington, A. J. P.
AU  - Bodenham, A. R.
TI  - Influenza A-induced rhabdomyolysis and acute kidney injury complicated by posterior reversible encephalopathy syndrome
JO  - Anaesthesia
VL  - 66
IS  - 8
SN  - 0003-2409
UR  - https://doi.org/10.1111/j.1365-2044.2011.06752.x
DO  - doi:10.1111/j.1365-2044.2011.06752.x
SP  - 738
EP  - 742
PY  - 2011
AB  - Summary We report a case of Influenza A-induced rhabdomyolysis causing acute kidney injury in a young adult female who required invasive ventilation and renal replacement therapy. This case was further complicated by posterior reversible encephalopathy syndrome. Although this represents an extremely rare neurological complication of Influenza A infection, an appreciation of the condition and its management is important, given the high numbers of critically ill patients recently affected by H1N1 Influenza A in intensive care units in the UK.
ER  - 

TY  - JOUR
TI  - ACCP 1998 ANNUAL MEETING ABSTRACTS
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 18
IS  - 2
SN  - 0277-0008
UR  - https://doi.org/10.1002/j.1875-9114.1998.tb03874.x
DO  - doi:10.1002/j.1875-9114.1998.tb03874.x
SP  - 426
EP  - 447
PY  - 1998
ER  - 

TY  - JOUR
TI  - Abstract
JO  - HPB
VL  - 10
IS  - S1
SN  - 1365-182X
UR  - https://doi.org/10.1080/13651820701867935
DO  - doi:10.1080/13651820701867935
SP  - 5
EP  - 226
PY  - 2008
ER  - 

TY  - JOUR
TI  - American Society of Transplant Surgeons: 20th Annual State of the Art Winter Symposium
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 20
IS  - S2
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.15715
DO  - doi:10.1111/ajt.15715
SP  - 13
EP  - 98
PY  - 2020
ER  - 

TY  - JOUR
AU  - Altassan, Ruqaiah
AU  - Péanne, Romain
AU  - Jaeken, Jaak
AU  - Barone, Rita
AU  - Bidet, Muad
AU  - Borgel, Delphine
AU  - Brasil, Sandra
AU  - Cassiman, David
AU  - Cechova, Anna
AU  - Coman, David
AU  - Corral, Javier
AU  - Correia, Joana
AU  - de la Morena-Barrio, María Eugenia
AU  - de Lonlay, Pascale
AU  - Dos Reis, Vanessa
AU  - Ferreira, Carlos R
AU  - Fiumara, Agata
AU  - Francisco, Rita
AU  - Freeze, Hudson
AU  - Funke, Simone
AU  - Gardeitchik, Thatjana
AU  - Gert, Matthijs
AU  - Girad, Muriel
AU  - Giros, Marisa
AU  - Grünewald, Stephanie
AU  - Hernández-Caselles, Trinidad
AU  - Honzik, Tomas
AU  - Hutter, Marlen
AU  - Krasnewich, Donna
AU  - Lam, Christina
AU  - Lee, Joy
AU  - Lefeber, Dirk
AU  - Marques-da-Silva, Dorinda
AU  - Martinez, Antonio F
AU  - Moravej, Hossein
AU  - Õunap, Katrin
AU  - Pascoal, Carlota
AU  - Pascreau, Tiffany
AU  - Patterson, Marc
AU  - Quelhas, Dulce
AU  - Raymond, Kimiyo
AU  - Sarkhail, Peymaneh
AU  - Schiff, Manuel
AU  - Seroczyńska, Małgorzata
AU  - Serrano, Mercedes
AU  - Seta, Nathalie
AU  - Sykut-Cegielska, Jolanta
AU  - Thiel, Christian
AU  - Tort, Federic
AU  - Vals, Mari-Anne
AU  - Videira, Paula
AU  - Witters, Peter
AU  - Zeevaert, Renate
AU  - Morava, Eva
TI  - International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 42
IS  - 1
SN  - 0141-8955
UR  - https://doi.org/10.1002/jimd.12024
DO  - doi:10.1002/jimd.12024
SP  - 5
EP  - 28
PY  - 2019
AB  - Abstract Phosphomannomutase 2 (PMM2-CDG) is the most common congenital disorder of N-glycosylation and is caused by a deficient PMM2 activity. The clinical presentation and the onset of PMM2-CDG vary among affected individuals ranging from a severe antenatal presentation with multisystem involvement to mild adulthood presentation limited to minor neurological involvement. Management of affected patients requires a multidisciplinary approach. In this article, a systematic review of the literature on PMM2-CDG was conducted by a group of international experts in different aspects of CDG. Our managment guidelines were initiated based on the available evidence-based data and experts' opinions. This guideline mainly addresses the clinical evaluation of each system/organ involved in PMM2-CDG, and the recommended management approach. It is the first systematic review of current practices in PMM2-CDG and the first guidelines aiming at establishing a practical approach to the recognition, diagnosis and management of PMM2-CDG patients.
ER  - 

TY  - JOUR
AU  - Au, Wing-Yan
AU  - Ma, Edmond S.
AU  - Lee, Tsz-Leung
AU  - Ha, Shau-Yin
AU  - Fung, Alvin T.
AU  - Lie, Albert K. W.
AU  - Kwong, Yok-Lam
TI  - Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab
JO  - British Journal of Haematology
VL  - 137
IS  - 5
SN  - 0007-1048
UR  - https://doi.org/10.1111/j.1365-2141.2007.06588.x
DO  - doi:10.1111/j.1365-2141.2007.06588.x
SP  - 475
EP  - 478
KW  - rituximab
KW  - thrombotic microangiopathy
KW  - haematopoietic stem cell transplantation
PY  - 2007
AB  - Summary Thrombotic microangiopathy (TMA) is a grave complication after haematopoietic stem cell transplantation (HSCT) and effective treatment is undefined. Five patients with postHSCT TMA, which was refractory to at least 1?week of plasma exchange and prednisolone, were treated with rituximab (375?mg/m2/week???4). Remission was achieved in four patients, of whom three remained in remission and one had died of sepsis at a median follow-up of 10?months. ADAMTS13 levels were low in all evaluable patients, and only one patient showed significant anti-ADAMTS13 antibody. The levels of ADAMTS13 and anti-ADAMTS13 antibody did not change significantly with rituximab-induced remission.
ER  - 

TY  - JOUR
TI  - Podium Presentations
JO  - BJU International
JA  - BJU Int
VL  - 123
IS  - S2
SN  - 1464-4096
UR  - https://doi.org/10.1111/bju.14724
DO  - doi:10.1111/bju.14724
SP  - 29
EP  - 53
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts-part VI (Continue in Part VII)
JO  - Proceedings of the International Society for Magnetic Resonance in Medicine
JA  - Proc. Soc. Magn. Reson. Med.
VL  - 1994
IS  - S1
SN  - 1065-9889
UR  - https://doi.org/10.1002/mrmp.22419940108
DO  - doi:10.1002/mrmp.22419940108
SP  - 301
EP  - 350
PY  - 1994
ER  - 

TY  - JOUR
AU  - D'Angelo, Antonio
AU  - Bellino, Claudio
AU  - Alborali, Giovanni L.
AU  - Borrelli, Antonio
AU  - Capucchio, Maria T.
AU  - Casalone, Cristina
AU  - Crescio, Maria I.
AU  - Mattalia, Gianni L.
AU  - Jaggy, Andre
TI  - Aortic Thrombosis in Three Calves with Escherichia coli Sepsis
JO  - Journal of Veterinary Internal Medicine
VL  - 20
IS  - 5
SN  - 0891-6640
UR  - https://doi.org/10.1111/j.1939-1676.2006.tb00736.x
DO  - doi:10.1111/j.1939-1676.2006.tb00736.x
SP  - 1261
EP  - 1263
PY  - 2006
ER  - 

TY  - JOUR
AU  - Mendel, Lionel
AU  - Albano, Laetitia
AU  - Bentellis, Imad
AU  - Yandza, Thierry
AU  - Bernardi, Caroline
AU  - Quintens, Herve
AU  - Tibi, Brannwel
AU  - Jourdan, Jacques
AU  - Durand, Matthieu
AU  - Amiel, Jean
AU  - Chevallier, Daniel
TI  - Safety of dual kidney transplantation compared to single kidney transplantation from expanded criteria donors: a single center cohort study of 39 recipients
JO  - Transplant International
JA  - Transpl Int
VL  - 31
IS  - 10
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.13280
DO  - doi:10.1111/tri.13280
SP  - 1110
EP  - 1124
KW  - dual kidney transplantation
KW  - extended criteria donor
KW  - graft shortage
KW  - kidney transplantation
KW  - surgical complication
PY  - 2018
AB  - Summary Our objective was to compare the outcomes of dual kidney transplanataion (DKT) to single kidney transplantation (SKT) performed with grafts from expanded criteria donors (ECD) in recipients ≥65 years, focusing on surgical complications. All kidney transplantations (KT) performed between 2006 and 2014 in our institution were analysed. DKT was indicated according to the criteria of the French national Agence de la Biomedecine. Thirty-nine DKT and 155 SKT were included, with a median follow-up of 36 and 26.5 months, respectively. The rate of early surgical revisions was not significantly higher after DKT (23.1% vs 15.5% (P = 0.2593)) but more venous graft thromboses (12.8% vs 3.2% (P = 0.02)) were reported. The glomerular filtration rate (GFR) 24 months after KT was significantly higher after DKT (45.0 ± 16.3 vs 39.8 ± 13.8 ml/min/1.73m2; P = 0.04) and allowed shorter waiting time without a significant increased risk of surgical revision, excepted for venous graft thrombosis, more frequent after DKT. Graft survivals were not significantly different and GFR was higher after DKT. DKT seems to remain an appropriate strategy to address the growing graft shortage in elderly patients.
ER  - 

TY  - JOUR
TI  - Concurrent Oral Sessions: Kidney
JO  - American Journal of Transplantation
VL  - 14
IS  - S3
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.12879
DO  - doi:10.1111/ajt.12879
SP  - 61
EP  - 151
PY  - 2014
ER  - 

TY  - JOUR
TI  - FREE COMMUNICATIONS  POSTER COMMUNICATIONS
JO  - Nephrology
VL  - 10
IS  - s1
SN  - 1320-5358
UR  - https://doi.org/10.1111/j.1440-1797.2005.00419.x
DO  - doi:10.1111/j.1440-1797.2005.00419.x
SP  - A1
EP  - A116
PY  - 2005
ER  - 

TY  - JOUR
TI  - Oral Sessions
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 98
IS  - S5
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.7577
DO  - doi:10.1002/bjs.7577
SP  - 1
EP  - 48
PY  - 2011
AB  - Abstract The 46th Congress of the European Society for Surgical Research takes place this year in Aachen, Germany, 25?28 May. Copyright ? 2011 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
AU  - He, Tianlin
C7  - 1800198
TI  - Implementation of Proteomics in Clinical Trials
JO  - PROTEOMICS – Clinical Applications
JA  - Prot. Clin. Appl.
VL  - 13
IS  - 2
SN  - 1862-8346
UR  - https://doi.org/10.1002/prca.201800198
DO  - doi:10.1002/prca.201800198
SP  - 1800198
KW  - clinical trials
KW  - diagnosis
KW  - prognosis
KW  - proteomic/protein assays
KW  - stratification
PY  - 2019
AB  - Abstract The application of protein (or peptide) biomarkers in clinical studies is a dynamic, ever-growing field. The introduction of clinical proteomics/peptidomics, such as mass spectrometry?based assays and multiplexed antibody?based protein arrays, has reshaped the landscape of biomarker identification and validation, allowing the discovery of novel biomarkers at an unprecedented rate and reliability. To reflect the current status with respect to implementation of protein/peptide biomarkers, an investigation of the most recent (last 6 years) clinical studies from clinicaltrials.gov is presented. Forty-two clinical trials involving the direct use of protein or peptide biomarkers in patient stratification and/or disease diagnosis and prognosis are highlighted. Most of the clinical trials that include proteomics/protein assays are aiming toward implementation of non-invasive diagnostic tools for early detection, while many of the clinical trials are targeting to correlate the protein abundance with the risk of a disease event. Less in number are the studies in which the protein biomarkers are applied to stratify the patients for intervention. All the above areas of application are considered of great importance for improving disease management, in an era where implementation toward precision medicine is the desired outcome of proteomics biomarker research.
ER  - 
